CERT Insider Trading Activity and SEC Form 4 Filings
Trump's trades in CERT
From his financial disclosures
$31K+
3 purchases
$31K+
3 sales
Purchase
Aug 31, 2026
Reported 38d later
$1K - $15K
Sale
May 15, 2026
Reported 47d later
$15K - $50K
Sale
Apr 30, 2026
Reported 62d later
$1K - $15K
Purchase
Mar 30, 2026
Reported 45d later
$15K - $50K
Sale
Feb 26, 2026
Reported 77d later
$15K - $50K
Purchase
Jan 26, 2026
Reported 108d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
CERT insider trading summary
Over the past 12 months, insiders at Certara, Inc. (CERT) reported 1 open-market purchase worth $200K by 1 insider and no sales on SEC Form 4. Net insider buying was $200K.
Latest CERT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 11, 2025 | William F Feehery | Chief Executive Officer | Buy | $200K (24,096.384 @ $8.30) |
| Sep 9, 2025 | Leif E Pedersen | President, Chief Commercal Off | Sell | $559K (51,224 @ $10.92) |
| Oct 7, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $60K (5,409 @ $11.03) |
| Sep 9, 2024 | Leif E Pedersen | President, Chief Commercal Off | Sell | $578K (51,224 @ $11.29) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $7K (422 @ $17.77) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $51K (3,024 @ $16.75) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $88K (5,264 @ $16.76) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $79K (4,740 @ $16.77) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $6K (328 @ $17.67) |
| Apr 2, 2024 | Patrick F Smith | President, Drug Dev Solutions | Sell | $12K (649 @ $17.72) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.